Histamine, Hay Fever and Why Symptoms Feel Worse Now

Originally published March 2026 · Updated May 2026 with the April 2026 Lancet Countdown Europe report on pollen seasons and climate change, the June 2025 eClinicalMedicine review on rising pollen allergy burden, and the latest UK allergic rhinitis treatment guidance

The 2026 Europe Report of the Lancet Countdown on Climate Change and Health — produced by 65 researchers from 46 academic and UN institutions — confirmed that the pollen season has become one to two weeks longer compared to the 1990s baseline. In the southern British Isles, the severity of birch and alder pollen seasons has increased by up to 20%. Pollen is also becoming stronger and stickier in more polluted environments, making individual pollen grains more allergenic per exposure.

At the same time, around 10 to 30% of the global population is now affected by allergic rhinitis — and the prevalence is rising, particularly in urban areas. The UK is among the worst affected countries in the world for hay fever and asthma.

But the worsening of symptoms is not just about more pollen. It reflects a more complex picture of how the immune system responds to allergens — a picture that the "histamine is the problem, antihistamine is the solution" framing has never fully captured.

TL;DR

• The 2026 Lancet Countdown Europe report confirmed pollen seasons are one to two weeks longer than in the 1990s. Pollen intensity in the southern British Isles has risen by up to 20% due to warmer temperatures and shifting climate patterns.
• Hay fever is a biphasic immune response — histamine drives the early phase (sneezing, itching, runny nose within minutes), but a second inflammatory phase drives the persistent congestion, fatigue, and sinus pressure that antihistamines alone cannot fully address.
• Pollen is becoming more allergenic — research shows it is increasingly strong and sticky in polluted environments, producing more severe symptoms per exposure.
• Thunderstorm asthma — where high winds concentrate pollen into smaller particles that penetrate deep into the lungs — is a rare but serious weather-related risk that can affect even mild hay fever sufferers.
• School students with active hay fever are 40% more likely to drop a grade between mock and final exams, rising to 70% with sedating antihistamines — making effective management a significant practical issue.
• The most evidence-backed treatment approach combines antihistamines for the early phase with nasal steroid sprays for the sustained inflammatory phase, plus immunotherapy for long-term desensitisation.

Why Hay Fever Is Getting Worse: The Climate Picture

The single most important reason hay fever symptoms are worsening at a population level is climate change — and the 2026 data is the most unambiguous yet.

Climate change has prolonged the pollen season by one to two weeks compared to the 1990s, increasing exposure duration for the millions of people living with hay fever and other allergies. In parts of eastern Europe, the southern British Isles, and northern France and Germany, the severity of birch and alder pollen seasons has increased by up to 20%.

The mechanisms are straightforward. Warmer spring temperatures cause trees and grasses to begin releasing pollen earlier. Extended warm periods push the end of the season later. Higher atmospheric CO2 increases plant growth rates and pollen production. And the interaction between pollen and air pollution compounds the biological effect — research has shown that pollen is becoming increasingly stronger and stickier to survive in more polluted environments, resulting in more severe expressions of symptoms in individuals with allergic rhinitis because the pollen is more potent.

For UK sufferers specifically, this means a season that previously ran roughly from late April to July now regularly extends from mid-March to August for tree pollen, with grass pollen — the most common UK allergen — peaking through June and July with increasing intensity.

The urban tree planting programmes designed to address climate change have inadvertently compounded the problem. One of the favourite species of trees for planting is birch trees because of its fast-growing properties. However, this species is highly allergenic with rates of birch pollen allergy continuing to rise.

The Biology: Why Histamine Is Only Part of the Story

Hay fever is formally called allergic rhinitis — and understanding it as an immune response rather than simply a histamine reaction explains both why antihistamines do not fully work and why symptoms are so variable between individuals and days.

Sensitisation: How It Starts

Hay fever does not begin with the first pollen exposure. It begins with sensitisation — the immune system's initial encounter with pollen proteins that programmes it to respond to future exposures.

During sensitisation, specific immune cells encounter pollen proteins and produce IgE antibodies tailored to those proteins. These IgE antibodies bind to mast cells — immune cells distributed throughout the nasal mucosa, skin, and airways — waiting for the next encounter with the same pollen.

This sensitisation process typically happens in childhood or early adulthood, though it can occur at any age. People who develop hay fever in their 30s or 40s are experiencing delayed sensitisation rather than early onset of an entirely new process.

The Early Phase: Histamine and Its Effects

When sensitised individuals encounter the relevant pollen again, the process unfolds rapidly. Pollen proteins bind to the IgE antibodies on mast cells, triggering immediate degranulation — the release of histamine and other preformed mediators into surrounding tissue.

Histamine then binds to H1 receptors throughout the nasal mucosa, conjunctiva, and airways, producing the classic early symptoms:

• Sneezing — histamine stimulates sensory nerve fibres in the nasal mucosa that trigger the sneeze reflex.
• Itching — histamine activates itch-mediating nerve fibres in the nose, eyes, and palate.
• Runny nose — histamine increases vascular permeability and mucus secretion.
• Watery eyes — histamine-driven vascular changes in the conjunctiva.

This early phase is rapid — typically beginning within minutes of pollen exposure — and this is where antihistamines are most effective. H1 receptor antagonists competitively block histamine binding, reducing the intensity of these early reactions.

The Late Phase: Why Congestion Persists

This is where most people's understanding of hay fever ends — and where most treatment strategies fall short.

Two to six hours after the initial reaction, a second inflammatory phase develops. This late phase is driven not by histamine but by the cytokines and chemokines released by mast cells during degranulation, which recruit additional immune cells — eosinophils, basophils, and T cells — into the nasal mucosa.

This cellular infiltration produces sustained inflammation that is responsible for:

• Nasal congestion — the dominant and most debilitating late-phase symptom, driven by blood vessel dilation and oedema in the nasal mucosa rather than histamine per se.
• Sinus pressure and pain — from the sustained inflammation of the sinus mucosa.
• Persistent fatigue — the systemic inflammatory burden of ongoing allergic disease, compounded by disrupted sleep from congestion.
• Heightened sensitivity — the inflamed mucosa becomes hypersensitive to non-allergic stimuli including cold air, exercise, and strong smells, producing symptoms triggered by exposures that would not normally cause them.

Antihistamines do not significantly address this late phase. This is why persistent congestion, fatigue, and sinus pressure often continue even when sneezing and itching are well controlled — and why treatment strategies that address only histamine are inherently incomplete.

The Nasal Barrier: The Underappreciated Factor

One of the most significant recent shifts in allergic rhinitis research is the recognition that the integrity of the nasal epithelial barrier — the lining of the nasal passages — is a critical determinant of symptom severity.

In healthy individuals, the nasal epithelium forms a continuous physical and immunological barrier that regulates which allergens penetrate into the mucosal tissue. When this barrier is disrupted — through inflammation, dryness, air pollution, or repeated allergen exposure — allergens penetrate more readily, lower doses trigger responses, and the immune reaction is amplified.

This reframes hay fever partly as a barrier maintenance problem. Supporting nasal barrier integrity — through adequate hydration, nasal saline rinses, and barrier sprays — reduces allergen penetration and the magnitude of the subsequent immune response. This is not instead of antihistamines or nasal steroids — it is complementary, addressing one of the most modifiable factors in symptom severity.

Thunderstorm Asthma: A Serious Weather Risk

One of the less commonly known but clinically significant weather-related hay fever complications is thunderstorm asthma — a rare but potentially serious event that can affect people with hay fever who have never had asthma.

Thunderstorm asthma is a rare event that can trigger an asthma attack for people with allergies. It is due to high winds drawing higher levels of pollens and pollution particles into the air. The pollen breaks down into smaller particles that when breathed in, can get deeper into the smaller airways of the lungs and trigger asthma symptoms.

People with hay fever who have never experienced asthma symptoms should be aware that during thunderstorms at peak pollen season — particularly when grass pollen counts are high — they may experience unexpected and severe respiratory symptoms. Remaining indoors with windows closed during thunderstorms in peak pollen season is the most effective preventive measure.

The Academic Performance Impact

The real-world functional impact of poorly managed hay fever is most strikingly illustrated by the data on academic performance — data that significantly raises the stakes of effective treatment.

School students with active hay fever sitting GCSE exams are 40% more likely to drop a grade between their mock and final exams, and 70% more likely if taking sedating antihistamines.

This finding — from a study published in the Journal of Allergy and Clinical Immunology — reflects the combined effects of disrupted sleep from congestion, the cognitive impairment of ongoing systemic inflammation, and the sedating side effects of first-generation antihistamines. GCSE final exams in England fall in May and June — precisely when grass pollen peaks.

For young people with hay fever, the choice of treatment matters enormously. Second-generation non-sedating antihistamines — loratadine, cetirizine, fexofenadine — do not produce the cognitive impairment of first-generation antihistamines like chlorphenamine. Nasal steroid sprays address the inflammatory component without sedation. The evidence strongly supports switching away from sedating antihistamines during exam periods and toward the combination approaches described below.

The Gut Microbiome and Allergy

One of the most significant longer-term contributors to rising hay fever prevalence is the gut microbiome — and the reduced microbial diversity that modern dietary patterns and antibiotic use have produced.

The immune system's propensity to mount allergic rather than tolerant responses to environmental proteins — including pollen — is shaped in early life by gut microbial exposure. The hygiene hypothesis — now more precisely framed as the biodiversity hypothesis — proposes that reduced exposure to diverse microbial environments in early life impairs the regulatory T cell development that prevents allergic sensitisation.

Gut microbiome diversity consistently differs between people with and without allergic disease. Short-chain fatty acids produced by gut bacterial fermentation of dietary fibre — particularly butyrate — directly support regulatory T cell function and immune tolerance. Diets low in diverse plant foods and high in ultra-processed foods reduce the microbial diversity and SCFA production that support immune regulation — contributing to the rising prevalence of allergic conditions at population level.

This does not mean that changing diet will cure established hay fever. It does mean that the same dietary foundations that support gut health — diversity of plant foods, adequate fibre, fermented foods — support the immune regulatory environment that moderates allergic responses.

Treatment: What Actually Works

Antihistamines — For the Early Phase

Second-generation non-sedating antihistamines — cetirizine, loratadine, fexofenadine — are the appropriate first-line treatment for early-phase symptoms. They are most effective when taken regularly throughout the pollen season rather than reactively when symptoms are already severe — because they reduce mast cell reactivity and baseline histamine load over time.

For most people, a daily non-sedating antihistamine is the right foundation. The key message for exam season and work: avoid first-generation antihistamines (chlorphenamine, promethazine) that cause sedation and cognitive impairment.

Nasal Steroid Sprays — For the Late Phase

Nasal corticosteroid sprays — fluticasone, mometasone, beclometasone — are the most evidence-backed treatment for the sustained inflammatory phase of allergic rhinitis. They reduce the eosinophilic and cellular inflammation that drives persistent congestion, sinus pressure, and fatigue.

They require consistent use — typically two weeks of regular application before maximal effect is achieved — which is why starting before the pollen season begins produces better outcomes than starting reactively. They are safe for long-term use at recommended doses and available over the counter in the UK.

For most people with moderate to severe hay fever, the combination of a non-sedating antihistamine and a nasal steroid spray addresses both phases of the response more effectively than either alone.

Immunotherapy — For Long-Term Desensitisation

Immunotherapy — subcutaneous or sublingual — is the only treatment that modifies the underlying immune response rather than managing symptoms. It involves gradually increasing exposure to the relevant allergen, retraining the immune system to tolerate rather than react to it.

Evidence for subcutaneous immunotherapy is strong — multiple systematic reviews confirm sustained symptom reduction after a three to five year course, with benefits persisting for years after treatment ends. Sublingual immunotherapy (drops or tablets taken under the tongue) has weaker evidence but is more accessible, available privately and through some NHS services.

Immunotherapy is appropriate for people with moderate to severe hay fever that is inadequately controlled by antihistamines and nasal steroids, those with comorbid asthma, and those who want to address the underlying condition rather than manage it seasonally for decades.

Nasal Barrier Sprays and Saline Rinses

Nasal saline rinses — using a neti pot, squeeze bottle, or saline spray — physically remove pollen from the nasal passages and support the mucosal barrier. Consistent use before and after high-pollen exposure reduces the allergen load reaching the nasal mucosa and the intensity of the subsequent immune response. The evidence is modest but consistent, and the intervention is safe, inexpensive, and additive to other treatments.

Specialised barrier sprays — cellulose or Vaseline-based formulations applied inside the nostrils — physically trap pollen particles before they contact the mucosa. Small randomised trials show meaningful symptom reduction as an adjunct to standard treatment.

Practical Daily Management During Peak Season

During high-pollen days — typically warm, dry, and breezy days between 5am and 10am and 5pm and 7pm when pollen is most concentrated at ground level:

• Timing matters. Pollen counts are highest in the morning and early evening. Outdoor exercise at midday or after rain — which clears pollen from the air — reduces exposure significantly.
• Sunglasses outdoors. Wrap-around sunglasses reduce the amount of pollen reaching the conjunctiva, reducing eye symptoms meaningfully.
• Shower after outdoor time. Pollen collects on hair, skin, and clothing. Showering and changing clothes after significant outdoor exposure reduces the indoor pollen load.
• Keep windows closed at peak times. Early morning and early evening windows allow peak pollen to enter indoor spaces.
• Vaseline around the nostrils. A thin application of Vaseline just inside the nostrils traps pollen before inhalation — a low-cost, accessible barrier intervention.
• Check the pollen forecast. The Met Office and Allergy UK provide daily pollen forecasts for the UK. Planning outdoor activities around low-pollen days and times during peak season is one of the most effective exposure-reduction strategies available.

Frequently Asked Questions

Why is my hay fever getting worse every year?

Several factors are driving this. The 2026 Lancet Countdown Europe report confirmed pollen seasons are one to two weeks longer than in the 1990s and pollen intensity in the southern British Isles has risen by up to 20%. Pollen is also becoming more allergenic in polluted environments. For individuals, immune sensitisation can intensify over time, and each high-pollen season can expand the range of allergens you react to — a process called epitope spreading.

Why don't antihistamines fully control my hay fever?

Because hay fever is a biphasic immune response. Antihistamines block histamine — the primary mediator of the early phase — effectively reducing sneezing, itching, and runny nose. But persistent congestion, sinus pressure, and fatigue are driven by a second inflammatory phase involving eosinophils and inflammatory cytokines that antihistamines do not significantly address. Nasal corticosteroid sprays target this second phase and produce better overall symptom control when combined with antihistamines.

What is the best treatment for hay fever in the UK?

The most evidence-backed approach for moderate to severe hay fever is daily non-sedating antihistamine combined with regular nasal corticosteroid spray, started two weeks before the season begins. This combination addresses both the early histamine-driven phase and the sustained inflammatory phase. For long-term improvement, allergen immunotherapy — available privately and through some NHS services — is the only treatment that modifies the underlying immune response rather than managing symptoms.

Can hay fever affect concentration and sleep?

Yes — significantly. Nasal congestion from hay fever disrupts sleep quality, and the systemic inflammatory burden of ongoing allergic disease impairs cognitive function. School students with active hay fever are 40% more likely to drop a grade between mocks and finals, rising to 70% with sedating antihistamines. Non-sedating antihistamines and nasal steroid sprays are the preferred treatments during exam periods for this reason.

Does the gut microbiome affect hay fever?

Increasingly, research suggests yes. Gut microbial diversity and short-chain fatty acid production support regulatory T cell function and immune tolerance — the mechanism that prevents allergic sensitisation. Diets low in diverse plant foods and high in ultra-processed foods reduce this protective immune regulation. While dietary change will not cure established hay fever, supporting gut microbiome diversity through plant-rich eating and fermented foods supports the immune regulatory environment that moderates allergic responses over time.

What is thunderstorm asthma?

Thunderstorm asthma is a rare but potentially serious event where high winds during thunderstorms concentrate pollen at ground level and break pollen grains into smaller particles that penetrate deeper into the airways. It can trigger severe respiratory symptoms in people with hay fever who have never had asthma. Remaining indoors with windows closed during thunderstorms in peak pollen season is the most effective preventive measure.

The Bottom Line

Hay fever is not getting harder to manage because sufferers are managing it badly. It is getting harder to manage because the environmental conditions driving it have changed — more pollen, starting earlier, lasting longer, and becoming more potent. The 2026 Lancet Countdown data makes this unambiguous.

The biology is also more complex than the antihistamine model suggests. A biphasic immune response requires a biphasic treatment approach — antihistamines for the histamine-driven early phase, nasal steroids for the inflammatory late phase, and for those with significant ongoing disease, immunotherapy to address the underlying immune sensitisation rather than managing it indefinitely.

The lifestyle foundations also matter — sleep quality, gut microbiome diversity, and reducing the systemic inflammatory load all influence how severely the body responds to allergen exposure. For a structured approach to reducing systemic inflammation and supporting immune resilience, the Histamine Reset from the Reset Series™ addresses the dietary and lifestyle factors most relevant to histamine-related conditions. The Gut Reset covers the microbiome foundations that support immune regulation. Pair either with the Reset Companion for personalised, day-to-day guidance.

Related reading: Histamine Intolerance: Real Condition or Misdiagnosed Sensitivity? · Why Most of Us Aren't Getting Enough Fibre — and How to Fix It · The Science Behind the Gut Reset

Popular Articles